New Releases from NCBI BookshelfAtogepant (Qulipta): Indication: For the prevention of migraine in adults who have at least 4 migraine days per month: CADTH Reimbursement Recommendation [Internet].Atogepant (Qulipta): Indication: For the prevention of migraine in adults who have at least 4 migraine days per month: CADTH Reimbursement Recommendation [Internet].
CADTH recommends that atogepant (Qulipta) be reimbursed by public drug plans for the prevention of migraine if certain conditions are […]
